Perhaps it is the start of the summer season but the market seems to have been quite the past couple of days or perhaps I am simply looking at the wrong parts of the market. 1. There were a number of EHA abstracts released today for PCYC and perhaps one of the most important was […]
May 20th – End Of Day Biotech Wrap-up
Outside of a not completely unexpected merger, it was a relatively quite start to the week. As has been par for the course, ASCO oncology stocks tended to be weak but not in a significant manner. Perhaps we are having the quite before the storm. 1. PPHM announced its agreement with the FDA on a […]
May 17th – End Of Day Biotech Wrap-up
It seemed to be a quite day as I think everyone is recovering from the ASCO abstract dump. 1. I had some good discussion with people about the PGNX abstract that I posted yesterday and wanted to go into a little more detail. PSMA is an antigen that is more likely to be expressed on […]
May 16 2013 – End Of Day Biotech Wrap-up
A lot of movers today and most were deep in the red. A lot of the moves were ASCO stocks selling off after the abstracts were released last night but some recovered (PCYC) while others stayed deep in the red (INFI) or moderately red (ARIA and MDVN). There is a lot to talk about but […]
May 15 2013 – End Of Day Biotech Wrap-up
Well, this is my first daily rundown for subscribers and while many of you have received these as emails, this might be new for others. In general, I like to take some of the more interesting stories of the day and put them into a context that would allow you to develop an effective trading […]
